VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $108,000 | +52.1% | 4,739 | +4.0% | 0.04% | +46.2% |
| Q1 2018 | $71,000 | -22.8% | 4,557 | 0.0% | 0.03% | -29.7% |
| Q4 2017 | $92,000 | +46.0% | 4,557 | 0.0% | 0.04% | +42.3% |
| Q3 2017 | $63,000 | -18.2% | 4,557 | 0.0% | 0.03% | -23.5% |
| Q2 2017 | $77,000 | +2466.7% | 4,557 | +1198.3% | 0.03% | +3300.0% |
| Q1 2017 | $3,000 | – | 351 | +963.6% | 0.00% | – |
| Q4 2016 | $0 | – | 33 | +26.9% | 0.00% | – |
| Q3 2016 | $0 | – | 26 | -55.9% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 59 | -64.2% | 0.00% | -100.0% |
| Q1 2016 | $3,000 | -50.0% | 165 | +79.3% | 0.00% | -50.0% |
| Q4 2015 | $6,000 | +20.0% | 92 | +196.8% | 0.00% | +33.3% |
| Q3 2015 | $5,000 | -28.6% | 31 | -6.1% | 0.00% | -25.0% |
| Q2 2015 | $7,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |